Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 81.41B | 77.06B | 70.85B | 66.39B | 62.12B |
Gross Profit | 9.89B | 9.53B | 8.66B | 8.52B | 7.74B |
EBITDA | 3.10B | 2.92B | 3.11B | 2.82B | 2.45B |
Net Income | 2.02B | 1.84B | 2.05B | 1.83B | 1.54B |
Balance Sheet | |||||
Total Assets | 46.62B | 47.73B | 43.88B | 41.56B | 40.19B |
Cash, Cash Equivalents and Short-Term Investments | 16.21B | 18.16B | 16.77B | 15.57B | 17.12B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 22.55B | 24.34B | 21.10B | 19.84B | 19.05B |
Stockholders Equity | 24.07B | 23.39B | 22.78B | 21.72B | 21.14B |
Cash Flow | |||||
Free Cash Flow | 1.59B | 2.54B | -525.17M | -136.90M | 673.91M |
Operating Cash Flow | 2.06B | 3.04B | 445.15M | 2.62B | 1.85B |
Investing Cash Flow | -2.17B | -219.47M | 1.92B | -2.89B | -1.28B |
Financing Cash Flow | -1.83B | -1.45B | -1.16B | -1.28B | -947.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.47B | 9.20 | 3.89% | 3.95% | -11.14% | ||
76 Outperform | ¥8.28B | 13.01 | 1.98% | 3.06% | -6.60% | ||
75 Outperform | ¥17.09B | 5.97 | 2.10% | 4.42% | 20.59% | ||
70 Outperform | ¥58.18B | 9.00 | 3.54% | 2.19% | 30.09% | ||
70 Outperform | ¥38.15B | 18.07 | 4.00% | 11.04% | 20.33% | ||
70 Outperform | ¥15.00B | 11.51 | 2.41% | 6.09% | -30.07% | ||
51 Neutral | $7.39B | 0.36 | -62.86% | 2.37% | 15.48% | -2.68% |